bNAb-1-18

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamebNAb-1-18
Drug Alias NamebNAb-1-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnvelope glycoprotein gp160 inhibitors
TargetsEnvelope glycoprotein gp160
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cologne
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Cologne
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A